The global life science and chemical instruments market is set to witness remarkable expansion, reaching an estimated value of USD 47.5 billion in 2024. With a steady compound annual growth rate (CAGR ...
BGI is one of the few companies in the world with the ability to independently develop sequencers, and is one of the few clinical-grade gene sequencers in the world that can independently develop and ...
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue from China, after the country banned the importation of its DNA ...
In sustainable agriculture, enhancing soil health and beneficial microbial interactions is vital for crop resilience and productivity. Common mycorrhizal networks (CMNs) play a key role in structuring ...
Illumina (NASDAQ:ILMN) on Monday lowered its adjusted profit outlook and cut spending costs for 2025 as the company grapples with a Chinese ban on its gene sequencers. Illumina now expects fiscal ...
Illumina (ILMN) said it is instituting an incremental approximately $100M cost reduction program for fiscal 2025. The company added, “These savings would mitigate the impact of a range of ...
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands ...
The Center for Genomics and Systems Biology (CGSB) at New York University Abu Dhabi (NYUAD) invites applications from individuals to be appointed as a Postdoctoral Associate in the Interdisciplinary ...
SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results